Sequential bypassing agents during major orthopedic surgery: a new approach to hemostasis

被引：3
|
作者：
Seaman, Craig D. [1 ,2 ]
Ragni, Margaret V. [1 ,2 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Dept Med, Dept Hematol Oncol, Pittsburgh, PA 15213 USA
[2] Hemophilia Ctr Western Penn, Pittsburgh, PA USA
来源：
BLOOD ADVANCES | 2017年 / 1卷 / 17期
关键词：
RECOMBINANT FACTOR VIIA; SEVERE HEMOPHILIA-A; INHIBITORS; MALES;
D O I：
10.1182/bloodadvances.2017008409
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1309 / 1311
页数：3
相关论文
共 50 条
  • [1] The effect of ulinastatin on hemostasis in major orthopedic surgery
    Lee, Jin Young
    Lee, Ji Young
    Chon, Jin Young
    Moon, Ho Sik
    Hong, Sung Jin
    [J]. KOREAN JOURNAL OF ANESTHESIOLOGY, 2010, 58 (01) : 25 - 30
  • [2] Changes in hemostasis during the perioperative period of orthopedic surgery
    Oberweis, B.
    Nardi, M. A.
    Cuff, G.
    Rosenberg, A.
    Pardo, L.
    Guo, Y.
    Marshall, M.
    Steiger, D.
    Stuchin, S.
    Berger, J. S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 470 - 470
  • [3] Prevention of venous thromboembolism after major orthopedic surgery: 'new' clinical trials for new antithrombotic agents
    Mismetti, P
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (12) : 2474 - 2476
  • [4] A Comparative Review of Two Major Topical Hemostasis Agents in Spine Surgery
    Chakraborty, Ashish D.
    Tong, Yixuan
    Fischer, Charla
    [J]. OPERATIVE TECHNIQUES IN ORTHOPAEDICS, 2024, 34 (01)
  • [5] APROTININ INFUSION DURING MAJOR ORTHOPEDIC-SURGERY
    OZAY, K
    DOGU, P
    ERKAL, H
    AYDM, F
    AZALI, G
    ARIKAN, Z
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1995, 74 : 61 - 61
  • [6] Health economic analyses of the use of bypassing agents in prophylaxis and major orthopedic surgeries in Swedish hemophilia patients with inhibitors
    Bonnet, P.
    Yoon, B.
    [J]. HAEMOPHILIA, 2008, 14 : 133 - 133
  • [7] Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents
    Mancuso, M. E.
    Chantarangkul, V.
    Clerici, M.
    Fasulo, M. R.
    Padovan, L.
    Scalambrino, E.
    Peyvandi, F.
    Tripodi, A.
    Santagostino, E.
    [J]. HAEMOPHILIA, 2016, 22 (04) : E292 - E300
  • [8] Major orthopaedic surgery for a haemophilia patient with inhibitors using a new bypassing agent
    Takedani, H.
    Hirose, J.
    Minamoto, F.
    Kubota, M.
    Kinkawa, J.
    Noguchi, M.
    [J]. HAEMOPHILIA, 2016, 22 (05) : E459 - E461
  • [9] Haemostatic treatment during major orthopedic surgery in haemophylic patients with inhibitors
    Buczma, A.
    Gwozdowska, A.
    Zbikowski, P.
    Ambroziak, P.
    Jurek, S.
    Windyga, J.
    [J]. HAEMOPHILIA, 2013, 19 : 81 - 82
  • [10] Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents
    Iorio, A
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (07) : 1055 - 1057
12345